IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 63
Titolo Data di pubblicazione Autore(i) File
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study 1-gen-2016 Bruzzone, M; Dellepiane, C; Bo, E; Cavo, A; Giannelli, F; Centurioni, Mg; Cosso, M; Alessandri, F; Vellone, VALERIO GAETANO; Sirito, R; Zanardi, Elisa; Buzzatti, G; Messina, C; Cattrini, C; Gustavino, C; Boccardo, Francesco
Combinations of hormonal therapy and chemotherapy 1-gen-2017 Ceresoli, G.; Bonomi, M.; Sauta, M. g.; Zanardi, Elisa; Boccardo, Francesco
Bone metastases from prostate cancer: hormonal therapy 1-gen-2017 Zanardi, Elisa; Cattrini, Carlo; Boccardo, Francesco
Baseline 18F-Fluoride PET-derived parameters predict modification of toxicity-and response-related blood biomarkers in prostate cancer patients treated with 223Ra-Dichloride: preliminary results 1-gen-2017 Ceriani, V; Fornarini, G; Bauckneht, M; Morbelli, S; Zanardi, E; Pomposelli, E; Buschiazzo, A; Calamia, I; Ippoliti, M; Fiz, F; Piva, R; Bettini, Pm; Boccardo, F; Sambuceti, G
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 1-gen-2017 Boccardo, F; Cavo, A; Zanardi, E; Fabbroni, C; Zinoli, L; Di Meglio, A; Arboscello, E; Bellodi, A; Spallarossa, P; Cattrini, C; Messina, C; Rubagotti, A
Targeting androgen-independent pathways: new chances for patients with prostate cancer? 1-gen-2017 Cattrini, C.; Zanardi, E.; Vallome, Giacomo; Cavo, A.; Cerbone, Luigi; Di Meglio, A.; Fabbroni, Chiara; Latocca, M. M.; Rizzo, Fabio; Messina, C.; Rubagotti, A.; Barboro, P.; Boccardo, F.
Risks and benefits from CDK inhibitors for advanced HR+ Her 2- breast cancer 1-gen-2017 Messina, C; Messina, M; Zanardi, E
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study 1-gen-2017 Cavo, A; Rubagotti, A; Bellodi, A; Zanardi, E; Zinoli, L; Spallarossa, P; Bagnato, P; Pane, B; Favorini, S; Barra, S; Arboscello, C; Arboscello, E; Palombo, D; Boccardo, F
Insights from a long-term follow-up evaluation of early breast cancer (BC) outcomes by tumor subtype (TS) 1-gen-2017 Zanardi, E.; Di Meglio, A.; Rubagotti, A.; Zinoli, L.; Salvi, S.; Boccardo, F.
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature 1-gen-2017 Gevorgyan, A; Bregni, G; Paolini, B; Galli, G; Zanardi, E; de Braud, F; Di Cosimo, S
May adjuvant therapy play a role for the management of renal cell carcinoma? A review of literature and ongoing trials 1-gen-2017 Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco
Neoplasie prostatiche 1-gen-2018 Boccardo, Francesco; Francini, Edoardo; Francini, Guido; Zanardi, Elisa
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 1-gen-2018 Lambertini, Matteo; Fontana, Valeria; Massarotti, Claudia; Poggio, Francesca; Dellepiane, Chiara; Iacono, Giuseppina; Abate, Annalisa; Miglietta, Loredana; Ferreccio, Chiara; Pescio, Maria Carolina; Conte, Benedetta; Blondeaux, Eva; Bighin, Claudia; D'Alonzo, Alessia; Vaglica, Marina; Zanardi, Elisa; Boccardo, Francesco; Ballestrero, Alberto; Anserini, Paola; Del Mastro, Lucia
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 1-gen-2018 Martel, Samuel; Poletto, Elena; Ferreira, Arlindo R.; Lambertini, Matteo; Sottotetti, Federico; Bertolini, Ilaria; Montemurro, Filippo; Bernardo, Antonio; Risi, Emanuela; Zanardi, Elisa; Ziliani, Serena; Mura, Silvia; Dellepiane, Chiara; Del Mastro, Lucia; Minisini, Alessandro Marco; Puglisi, Fabio
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials 1-gen-2018 Messina, Carlo; Cattrini, Carlo; Buzzatti, Giulia; Cerbone, Luigi; Zanardi, Elisa; Messina, Marco; Boccardo, Francesco
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer 1-gen-2018 Cattrini, Carlo; Zanardi, Elisa; Boccardo, Francesco
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 1-gen-2018 Cavo, Alessia; Rubagotti, Alessandra; Zanardi, Elisa; Fabbroni, Chiara; Zinoli, Linda; Di Meglio, Antonio; Arboscello, Eleonora; Bellodi, Andrea; Spallarossa, Paolo; Cattrini, Carlo; Messina, Carlo; Boccardo, Francesco
Management of advanced endometrial cancer 1-gen-2018 Zanardi, E.; Latocca, M. M.
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 1-gen-2018 Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Buzzatti, Giulia; Vallome, Giacomo; Rizzo, Fabio; Cavo, Alessia; Beshiri, Kristi; Soldato, Davide; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco
EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS 1-gen-2018 Messina, C; Messina, M; Cattrini, C; Cerbone, L; Mastrocinque, G; Zanardi, E; Spatafora, P
Mostrati risultati da 21 a 40 di 63
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile